| 000 | 01071 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516001905.0 | ||
| 264 | 0 | _c20100910 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.2010.1302 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Reilly, Eileen M | |
| 245 | 0 | 0 |
_aRefinement of adjuvant therapy for pancreatic cancer. _h[electronic resource] |
| 260 |
_bJAMA _cSep 2010 |
||
| 300 |
_a1124-5 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tJAMA _gvol. 304 _gno. 10 _gp. 1124-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.2010.1302 _zAvailable from publisher's website |
| 999 |
_c20155917 _d20155917 |
||